Skip to main content
  1. Market Insights
  2. Health
  3. Pharmacies
  4. OTC Products

Analgesics (Pharmacies) - Sweden

Sweden
  • Revenue in the Analgesics market is projected to reach US$159.15m in 2025.
  • Revenue is expected to show an annual growth rate (CAGR 2025-2029) of 3.46%, resulting in a market volume of US$182.37m by 2029.
  • In global comparison, most revenue will be generated China (US$5.48bn in 2025).
  • In relation to total population figures, per person revenues of US$14.83 are generated in 2025.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope
  • Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
  • Natural and synthetic agents
  • In the form of pills, capsules, gels and ointments
Out-Of-Scope
  • Prescription medicines
  • Homeopathic remedies
  • Anesthetics
OTC Products: market data & analysis - Cover

Market Insights report

OTC Products: market data & analysis
Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Analyst Opinion

    The Analgesics (Pharmacies) market in Sweden has been experiencing steady growth in recent years.

    Customer preferences:
    Swedish consumers have shown a growing preference for analgesics purchased from pharmacies rather than other retail channels. This is due to the perception that pharmacies offer a wider range of products and higher quality brands. Additionally, pharmacies in Sweden are known for their knowledgeable staff who can provide expert advice on pain relief options.

    Trends in the market:
    One of the key trends in the Analgesics market in Sweden is the increasing demand for natural and herbal pain relief products. Swedish consumers are becoming more health-conscious and are seeking alternatives to traditional pharmaceuticals. This trend is driven by a desire for products with fewer side effects and a preference for natural ingredients. As a result, pharmacies in Sweden have been expanding their range of natural and herbal analgesics to meet this growing demand. Another trend in the market is the rising popularity of online pharmacies. Swedish consumers are increasingly turning to online platforms to purchase analgesics due to the convenience and accessibility they offer. Online pharmacies provide a wide selection of products, competitive prices, and the convenience of home delivery. This trend has been further accelerated by the COVID-19 pandemic, which has led to a greater emphasis on e-commerce and online shopping.

    Local special circumstances:
    One of the unique aspects of the Analgesics market in Sweden is the strong regulatory framework governing the sale of pharmaceutical products. The Swedish Medicines Agency (Läkemedelsverket) regulates the marketing and sale of analgesics to ensure their safety and efficacy. This strict regulatory environment ensures that only high-quality products are available in the market, which enhances consumer trust and confidence in pharmacies.

    Underlying macroeconomic factors:
    The growth of the Analgesics market in Sweden can be attributed to several macroeconomic factors. Firstly, Sweden has a high standard of healthcare and a strong emphasis on preventive medicine, which has led to a greater focus on pain management and the use of analgesics. Additionally, the aging population in Sweden has contributed to the increased demand for pain relief products, as older individuals are more likely to experience chronic pain conditions. Furthermore, the strong economy in Sweden has provided consumers with higher disposable incomes, allowing them to spend more on healthcare products, including analgesics. The stable economic conditions and high levels of consumer confidence have also encouraged investment in the healthcare sector, leading to the expansion of pharmacies and the availability of a wider range of analgesics. In conclusion, the Analgesics (Pharmacies) market in Sweden is experiencing growth due to customer preferences for pharmacy channels, the increasing demand for natural and herbal pain relief products, the rising popularity of online pharmacies, the strong regulatory framework governing pharmaceutical sales, and underlying macroeconomic factors such as a high standard of healthcare and a strong economy.

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

    Modeling approach:

    Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

    Additional notes:

    The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    OTC Products: market data & analysis - BackgroundOTC Products: market data & analysis - Cover

    Explore more high-quality data on related topic

    Pharma e-commerce – statistics & facts

    The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)